WEE1 and small cell lung carcinoma: Based on previous studies targeting other DDR proteins including CHK1 and PARP, we hypothesized that WEE1 inhibition may activate antitumor immunity in SCLC (Sen et al., 2019a, 2019b; Zhang et al., 2020).